Adenosine A(2A) receptor interactions with receptors for other neurotransmitters and neuromodulators

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 101-113

  Ribeiro, J Alexandre ^a  

^a UNIVERSITY OF LISBON   (Portugal)

Author keywords

Adenosine; Adenosine A(2A) receptor; CGRP (calcitonin gene related peptide); Dopamine receptor; Glutamate receptor; Neuroprotection; Nicotinic receptor; Receptor interaction; VIP (vasoactive intestinal peptide)

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CAFFEINE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NICOTINIC RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; ADENOSINE RECEPTOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GUANINE NUCLEOTIDE BINDING PROTEIN;

CHEMICAL STRUCTURE; NEUROMODULATION; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; METABOLISM; PHYSIOLOGY;

ADENOSINE; ANIMALS; GTP-BINDING PROTEINS; NEUROTRANSMITTER AGENTS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1;

EID: 0032587930     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00230-7     Document Type: Review

References (127)

1. 2 receptors. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 227:1992;317-324.
2. Alexander S.P., Reddington M. The cellular localization of adenosine receptors in rat neostriatum. Neuroscience. 28:1989;645-651.
3. 2b adenosine receptor-stimulated cyclic AMP accumulation. Neurosci. Lett. 146:1992;231-233.
4. 2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta. Mol. Cell. Endocrinol. 62:1989;273-279.
5. 2A receptor ligand binding site. J. Neurochem. 63:1994;1477-1484.
6. 2A receptor mRNA is expressed by enkephalin cells but not by somastotatin cells in rat striatum: a co-expression study. Mol. Brain Res. 22:1994;204-210.
7. 2 receptor-selective drugs on brain stimulation reward thresholds in the rat. Behav. Pharmacol. 9:1998;S12. Suppl. 1.
8. Barraco R.A., Ergene E., El-Ridi M. Purinergic receptors in the nucleus tractus solitarius mediate distinct cardiorespiratory response patterns. Drug Dev. Res. 28:1993;309-314.
9. 2 adenosine receptor binding subunit by photoaffinity crosslinking. Proc. Natl. Acad. Sci. USA. 86:1989;6572-6576.
10. 2-adenosine receptor binding subunit. Mol. Pharmacol. 38:1990;177-183.
11. Biaggioni I., Paul S., Puckett A., Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists. J. Pharmacol. Exp. Ther. 258:1991;588-593.
12. 2 receptors in bovine retinal membranes. Exp. Eye Res. 56:1993;585-593.
13. Canhão P., de Mendonça A., Ribeiro J.A. 1,3-Dipropyl-8-cyclopentylxanthine attenuates the NMDA response to hypoxia in the rat hippocampus. Brain Res. 661:1994;265-273.
14. 2A receptors on soma and central terminals of rat vagal afferent neurons. Brain Res. 652:1994;137-144.
15. 2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells. J. Neurochem. 69:1997;1300-1309.
16. Chern Y.-J., King K., Lai H.-L., Lai H.-T. Molecular cloning of a novel adenosine receptor gene from rat brain. Biochem. Biophys. Res. Commun. 185:1992;304-309.
17. 2A adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol. Pharmacol. 44:1993;950-958.
18. 2. Mol. Pharmacol. 48:1995;1-8.
19. 2 receptor-mediated excitation of a subset of AH/type 2 neurons and elevation of cAMP levels in myenteric ganglia of guinea-pig ileum. Neurogastroenterol. Mot. 6:1994;67-78.
20. 2-adenosine receptor activation Neurosci. Lett. 151:1993;21-24.
21. 3H ]-acetylcholine release from rat motor nerve endings Br. J. Pharmacol. 111:1994;582-588.
22. 2A-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;514-522.
23. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur. J. Pharmacol. 271:1994;349-355.
24. Correia-de-Sá P., Sebastião A.M., Ribeiro J.A. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat. Br. J. Pharmacol. 103:1991;1614-1620.
25. Correia-de-Sá P., Timóteo M.A., Ribeiro J.A. VIP-induced facilitation of neuromuscular transmission depends on tonic A′A-adenosine presynaptic receptors activation. Proc. Soc. Port. Farmacol. Abstr. 49:1998.
26. Cunha R.A., Sebastião A.M. Extracellular metabolism of adenine nucleotides and adenosine in the innervated skeletal muscle of the frog. Eur. J. Pharmacol. 197:1991;83-92.
27. Cunha R.A., Sebastião A.M. Adenosine and adenine nucleotides are independently released from both the nerve terminals and the muscle fibres upon electrical stimulation of the innervated skeletal muscle of the frog. Pflugers Arch. 424:1993;503-510.
28. Cunha R.A., Sebastião A.M., Ribeiro J.A. Ecto-5′-nucleotidase is associated with cholinergic nerve terminals in the hippocampus but not in the cerebral cortex of the rat. J. Neurochem. 59:1992;657-666.
29. 2A receptors in the rat hippocampus. Brain Res. 649:1994;208-216.
30. 3H ]-acetylcholine release from different areas of the rat hippocampus J. Neurochem. 63:1994;207-214.
31. 3H ]-acetylcholine release from the hippocampus and cerebral cortex of the rat: role of the ectonucleotidases Eur. J. Neurosci. 6:1994;33-42.
32. 2A adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. NeuroReport. 6:1995;1583-1588.
33. 2A receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;261-271.
34. Cunha R.A., Correia-de-Sá P., Sebastião A.M., Ribeiro J.A. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119:1996;253-260.
35. 3H-GABA release from rat hippocampal synaptosomes Proc. Soc. Port. Farmacol. Abstr. 2:1998.
36. Daly J.W., Butts-Lamb P., Padgett W. Subclasses of adenosine receptors in the central nervous system. Interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 1:1983;69-80.
37. 2 receptors in stably cotransfected fibroblast cells. Eur. J. Pharmacol. 316:1996;325-331.
38. 1 receptor activation. NeuroReport. 6:1995;1097-1100.
39. 2A receptors gene: relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region. Hum. Genet. 99:1997;326-328.
40. 2A receptor in rat striatum. J. Neurochem. 69:1997;315-321.
41. Dowdall M.J., Boyne A.F., Whittaker V.P. Adenosine triphosphate. A constituent of cholinergic synaptic vesicles. Biochem. J. 140:1974;1-12.
42. Ferré S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology. 133:1997;107-120.
43. 2 receptors in the neostriatum. Brain Res. 594:1992;124-130.
44. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA. 88:1991;7238-7241.
45. Ferré S., Fuxe K., von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512.
46. Ferré S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5402-5406.
47. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
48. 2 dopamine receptors in rat striatum. Mol. Brain Res. 14:1992;186-195.
49. 2 adenosine receptor. Mol. Brain Res. 15:1992;62-66.
50. 1 receptor interactions in the basal ganglia. Brain Res. Rev. 26:1998;258-273.
51. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
52. Gonçalves J., Queiroz G. Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epidendymal portion of rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 348:1993;367-371.
53. Green R.D., Proudfit H.K., Yeung S.-M.H. Modulation of striatal dopaminergic function by local injection of 5′-N-ethylcarboxamide adenosine. Science. 218:1982;58-61.
54. 2 receptors in rat brain. Brain Res. Bull. 21:1988;479-482.
55. Herrera-Marschitz M., Casas M., Ungerstedt U. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Psychopharmacology. 94:1988;38-45.
56. 2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41:1992;352-359.
57. 2A receptor. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268:1994;95-104.
58. 2A-adenosine receptors. Mol. Pharmacol. 42:1992;123-133.
59. 2A adenosine receptors. Drug Dev. Res. 28:1993;226-231.
60. James S., Richardson P.J. Production of adenosine from extracellular ATP at striatal cholinergic synapse. J. Neurochem. 60:1993;219-227.
61. James S., Xuereb J.H., Askalan R., Richardson P.J. Adenosine receptors in post-mortem human brain. Br. J. Pharmacol. 105:1992;238-244.
62. 3H ]CGS 21680 Eur. J. Pharmacol. 168:1989;243-246.
63. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267:1993;801-808.
64. 3H ]CGS 21680 to rat brain using autoradiography Neuropharmacology. 34:1995;393-403.
65. 2 receptors in rat striatum. Biochem. Pharmacol. 44:1992;2365-2370.
66. 3H ]CGS 21680 to rat cortex differs from its binding to rat striatum Eur. J. Pharmacol., Mol. Pharmacol. Sect. 247:1993;103-110.
67. Josselyn S.A., Beninger R.J. Behavioural effects of intrastriatal caffeine mediated by adenosinergic modulation of dopamine. Pharmacol. Biochem. Behav. 39:1991;97-103.
68. 2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmacol. 295:1996;147-154.
69. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian models. Ann. Neurol. 43:1998;507-513.
70. 1 and 2-chloroadenosine. Mol. Pharmacol. 20:1981;585-591.
71. 3H ]-CGS 21680 binding sites in the rat striatum and cortex Br. J. Pharmacol. 114:1995;537-543.
72. Lawrence A.J., Krstew E., Jarrott B. Adenosine-dopamine receptor interactions in the isolated rat nodose ganglion but not in membranes of dorsal vagal complex. Naunyn-Schmiedeberg's Arch. Pharmacol. 355:1997;303-308.
73. 2A. Biochem. Biophys. Res. Commun. 223:1996;461-467.
74. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol. Sci. 15:1994;298-306.
75. 2 receptors. Trend Pharmacol. Sci. 12:1991;326-328.
76. 2A receptor (ADORA2) to chromosome 22. Genomics. 20:1994;332-333.
77. 2 receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173:1990;1169-1178.
78. 2-adenosine receptor to stimulatory guanine nucleotide-binding-protein in bovine brain striatum. J. Pharmacol. Exp. Ther. 266:1993;294-300.
79. Marsal J., Solsona C., Rabasseda X., Blasi J., Casanova A. Depolarization-induced release of ATP from cholinergic synaptosomes is not blocked by botulinum toxin type A. Neurochem. Int. 10:1987;295-302.
80. 2 receptor interaction in globus pallidus. Synapse. 22:1996;132-138.
81. 2+ ion. Biochem. Biophys. Acta. 1220:1993;76-84.
82. 2A adenosine receptor from guinea pig brain. Neurochem. Res. 19:1994;613-621.
83. 2A receptor agonists increase Fos-like immunoreactivity preferentially in the limbic system: similarities with atypical antipsychotics. Behav. Pharmacol. 9:1998;S66. Suppl. 1.
84. 2 receptors in unilaterally 6-hydroxidopamine-lesioned rats. Eur. J. Pharmacol. 251:1994;21-25.
85. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience. 67:1995;49-55.
86. 2-adenosine receptor. J. Recept. Res. 13:1993;961-973.
87. 2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol. 39:1991;130-135.
88. Newman M.E., Levitzki A. Desensitization of normal rat kidney cells to adenosine. Biochem. Pharmacol. 32:1983;137-140.
89. 2 receptor antagonist, to rat brain membranes Mol. Pharmacol. 46:1994;817-822.
90. Norenberg W., Wirkner K., Illes P. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones. Br. J. Pharmacol. 122:1997;71-80.
91. 2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol. 362:1998;17-25.
92. Ongini E., Dionisotti S., Gessi S., Irenius E., Fredholm B.B. Comparison of CGS15943, ZM241385 and SCH58261 as antagonists of human adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 359:1999;7-10.
93. 2 adenosine receptors by two antipeptide antibody preparations. Mol. Pharmacol. 42:1994;391-397.
94. 2a adenosine receptor: delineation of multiple processes. Mol. Pharmacol. 45:1994;1082-1094.
95. 2A receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. J. Neurochem. 64:1995;2057-2064.
96. Paul S., Kurunwune B., Biaggioni I. Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets. J. Pharmacol. Exp. Ther. 267:1993;838843.
97. 2A adenosine receptors retain ligand binding characteristics. Mol. Pharmacol. 45:1994;861-870.
98. Pitcher J.A., Freedman N.J., Lefkowitz R.J. G-protein-coupled receptor kinases. Annu. Rev. Biochem. 67:1998;653-692.
99. Popoli P., Betto P., rimondini R., Pézzola A., Ricciarello G., Fuxe K., Ferré S. Age-related alteration of the adenosine/dopamine balance in the rat striatum. Brain Res. 795:1998;297-300.
100. Porter N.M., Radulovacki M., Green R. Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogues. J. Pharmacol. Exp. Ther. 244:1988;218-225.
101. 1 MF-2 cells. Mol. Pharmacol. 40:1991;639-647.
102. Redman R.S., Silinsky E.M. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings. J. Physiol. (London). 477:1994;117-127.
103. Ribeiro J.A., Sebastião A.M. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J. Physiol. (London). 384:1987;571-585.
104. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci. 18:1997;338-344.
105. 2A agonists: a potential new type of atypical antipsychotics. Neuropsychopharmacology. 17:1997;82-91.
106. 2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur. J. Pharmacol. 347:1998;153-158.
107. Rodrigo J., Polak J.M., Fernandez L., Ghatei M.A., Mulderry P., Bloom S.R. Calcitonin gene-related peptide immunoreactive sensory and motor nerves of the rat, cat, and monkey esophagus. Gastroenterology. 88:1985;129-135.
108. 2A adenosine receptor mRNA expression by agonists and forskolin in PC12 cells. NeuroReport. 5:1994;1317-1320.
109. Sattin A., Rall T.W., Zanella J. Regulation of cyclic adenosine 3′-5′-monophosphate levels in guinea pig cerebral cortex by interaction of alpha adrenergic and adenosine receptor activity. J. Pharmacol. Exp. Ther. 192:1975;22-32.
110. 2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13:1993;1080-1087.
111. 2 receptor regulation of striatal gene expression. In: Bellardinelli, L., Pelleg, A. (Eds.), Adenosine and Adenine Nucleotides: from Molecular Biology to Integrative Physiology. Kluwer Academic Publishers, Boston, pp. 71-76.
112. 2 receptor mRNA in the human brain. Neurosci. Lett. 130:1991;177-181.
113. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
114. 2 adenosine receptors in the rat hippocampus. Neurosci. Lett. 138:1992;41-44.
115. Sebastião A.M., Stone T.W., Ribeiro J.A. The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br. J. Pharmacol. 101:1990;453-459.
116. Sebastião A.M., Macedo M.P., Ribeiro J.A. 'Fine tune' modulation of neurotransmission in the hippocampus by adenosine. Drug Dev. Res. 43:1998;59.
117. Shi D., Nikodijevic O., Jacobson K.A., Daly J.W. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Arch. Int. Pharmacodyn. 328:1994;261-287.
118. Silinsky E.M. On the association between transmitter secretion and the release of adenine nucleotides from mammalian motor nerve terminals. J. Physiol. (London). 247:1975;145-162.
119. Svenningson P., Nomikos G.G., Fredholm B.B. Biphasic changes in locomotor behavior and in expression of nRNA for NGF1-A and NGF1-B in rat striatum following acute caffeine administration. J. Neurosci. 15:1995;7612-7624.
120. 2 receptor regulation of apomorphine-induced turning in rats with unilateral striatal dopamine denervation. Psychopharmacology. 111:1993;383-388.
121. Von Lubitz D.K.J.E. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol. 365:1999;9-25.
122. 3H ]CGS 21680 to human and rat brain: evidence for multiple affinity sites J. Neurochem. 55:1990;1763-1771.
123. 2A adenosine receptor gene expression in developing rat brain. Mol. Brain Res. 20:1993;313-327.
124. 3H ]Acetylcholine release from the phrenic nerve is increased or decreased by activation or desensitization of nicotinic receptors Eur. J. Pharmacol. 135:1987;85-87.
125. Winder D.G., Conn P.J. Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine. J. Neurosci. 13:1993;38-44.
126. 2 receptors in the striatum. Neurosci. Lett. 41:1983;55-60.
127. Zhang J., Wells J.N. Effects of chronic caffeine administration on peripheral adenosine receptors. J. Pharmacol. Exp. Ther. 254:1990;270-276.